文献速递消化内镜消化道出血

抗血栓治疗对内镜黏膜下剥离术后出血的影响

Effects of antithrombotic therapy on bleeding after endoscopic submucosal dissection.
PubMed 文献 · Gastrointest Endosc · 2017-07-19

该Meta分析与系统综述检索至2017年1月的文献,纳入16项回顾性研究,评估抗血栓治疗与内镜黏膜下剥离术后出血的关联。结果显示抗血栓治疗显著增加术后出血风险(OR 1.66),尤其是迟发出血(OR 2.66);持续使用低剂量阿司匹林未显著增加出血风险(OR 1.22)。

要点

  • 抗血栓治疗显著增加内镜黏膜下剥离术后出血风险,尤其是迟发出血。
  • 停用多种抗血栓药、1周内恢复抗血栓药及肝素替代均显著增加出血风险。
  • 持续使用低剂量阿司匹林未显著增加出血风险。

核心结论

  • 抗血栓治疗是内镜黏膜下剥离术后出血的危险因素,尤其是迟发出血。
  • 使用多种抗血栓药、1周内恢复抗血栓药和肝素替代与术后出血显著相关,但持续使用低剂量阿司匹林未显著增加出血风险。
  • 作者指出仍需更大规模的前瞻性研究。

研究设计与样本

  • Meta分析与系统综述,检索在线数据库截至2017年1月的已发表文献。
  • 由2名独立评价者使用标准表格提取数据,采用纽卡斯尔-渥太华量表评分评估研究质量。
  • 纳入16项回顾性文章。

主要发现

  • 无论停药(OR 1.66;95%CI 1.15-2.39;P=0.007)还是继续用药(OR 8.39;95%CI 4.64-15.17;P<0.00001),抗血栓治疗均与内镜黏膜下剥离术后出血显著相关,尤其与迟发出血相关(OR 2.66;95%CI 1.42-4.98;P=0.002)。
  • 停用多种抗血栓药组的出血率(OR 5.17;95%CI 3.13-8.54;P<0.00001)高于停用单一抗血栓药组(OR 2.23;95%CI 1.29-3.85;P=0.004)和单一抗血小板药组(OR 2.08;95%CI 0.93-4.63;P=0.07)。
  • 亚组分析中,1周内恢复抗血栓药(OR 2.46;95%CI 1.54-3.93;P=0.0002)和使用肝素替代(OR 4.20;95%CI 1.94-9.09;P=0.0003)显著增加内镜黏膜下剥离术后出血风险。
  • 持续使用低剂量阿司匹林(OR 1.22;95%CI 0.17-8.61;P=0.84)未显著增加出血风险。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 纳入的16项研究均为回顾性研究。
  • 作者指出仍需更大规模的前瞻性研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Bleeding is the most common adverse event after endoscopic submucosal dissection (ESD). Although several studies have reported on the use of antithrombotic agents and post-ESD bleeding, many issues remain controversial. We conducted a meta-analysis and systematic review to evaluate the effects of antithrombotic therapy on post-ESD bleeding. METHODS: The published literature was searched on online databases, and all studies were included up to January 2017. Standard forms were used to extract data by 2 independent reviewers. The Newcastle-Ottawa Scale score was used to assess the quality of studies. The pooled odds ratio (OR) was computed for the effect of antithrombotic agents. Publication bias was assessed by funnel plots. Heterogeneity was assessed by the Cochran Q test and I2 statistic. RESULTS: Sixteen retrospective articles were included. Regardless of discontinuation (OR, 1.66; 95% confidence interval [CI], 1.15-2.39; P = .007) or continuation (OR, 8.39; 95% CI, 4.64-15.17; P < .00001), antithrombotic therapy was significantly associated with post-ESD bleeding, particularly for delayed bleeding (OR, 2.66; 95% CI, 1.42-4.98; P = .002). The bleeding rate was higher in the discontinued multiple antithrombotics group (OR, 5.17; 95% CI, 3.13-8.54; P < .00001) than in the discontinued a single antithrombotic group (OR, 2.23; 95% CI, 1.29-3.85; P = .004) and single antiplatelet group (OR, 2.08; 95% CI, 0.93-4.63; P = .07). In the subgroup analysis, resuming antithrombotics within 1 week (OR, 2.46; 95% CI, 1.54-3.93; P = .0002) and using heparin replacement (OR, 4.20; 95% CI, 1.94-9.09; P= .0003) significantly increased post-ESD bleeding risk. Continued use of low-dose aspirin (OR, 1.22; 95% CI, 0.17-8.61; P = .84) did not significantly increase the bleeding risk. CONCLUSIONS: Antithrombotic therapy is a risk factor for post-ESD bleeding, especially for delayed bleeding. Using multiple antithrombotic drugs, resuming antithrombotics within 1 week, and heparin replacement were significantly associated with post-ESD bleeding; but continuous low-dose aspirin was not. However, much larger prospective studies are required.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Dong J, Wei K, Deng J, et al. Effects of antithrombotic therapy on bleeding after endoscopic submucosal dissection. Gastrointest Endosc. 2017. PMID: 28732709. doi:10.1016/j.gie.2017.07.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。